Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zilretta for Thumb CMC Osteoarthritis
NCT06237153Phase 2Recruiting
- Start
- Nov 2023
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of triamcinolone acetonide in carpometacarpal osteoarthritis (2 arms). Primary endpoint: Visual Analog Pain Score. Started Nov 2023; status: recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
carpometacarpal osteoarthritis
Beyond the preview
Go deeper on NCT06237153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06237153.